Rusi Pharma Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1992PTC069066 Incorporated 16 October 1992 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2020
₹3.81 Cr
▼ 68% YoY
Net loss · FY 2020
₹3.43 Lakh
Net margin -0.9%
EBITDA · FY 2020
₹29.57 Lakh
EBITDA margin 7.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Satisfied charges
₹6.01 Cr
No open charges
Company age
34 yrs
Est. 1992
Directors on board
2
As per MCA filings

About Rusi Pharma Pvt Ltd

Data last updated:

Rusi Pharma Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1992PTC069066. Its GSTIN is 05AAACR3203M2ZM (Uttarakhand). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Monika and Sudhir Kumar.

Its last annual general meeting (AGM) was held on 03 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2020, the company reported a revenue of ₹3.81 Cr, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹3.43 Lakh (net margin -0.9%) and EBITDA of ₹29.57 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 50% over five years.

As per MCA filings, the company has satisfied charges of ₹6.01 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rusipharma.com.

Company details

CIN U24230MH1992PTC069066
Registration Number 069066
Incorporation Date 16 October 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 03 October 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant

Contact details

Rusi Pharma Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is rusipharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Anchor Building A Flat No.4D/104 New Mhada Complex Bhoomi Construction Malwani Mal, Ad West, Mumbai, Maharashtra, India – 400096
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Rusi Pharma Pvt Ltd, buy the company report.

Comprehensive company report
Rusi Pharma Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rusi Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Rusi Pharma Pvt Ltd, buy the company report.

Financials of Rusi Pharma Pvt Ltd

FY 2020 filings available

Rusi Pharma Pvt Ltd reported revenue of ₹3.81 Cr (down 68% YoY) for FY 2020.

Revenue · FY 2020
₹3.81 Cr ▼ 68%
Net loss · FY 2020
₹3.43 Lakh margin -0.9%
EBITDA · FY 2020
₹29.57 Lakh margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 10%
5 years · compounded
▲ 50%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 6%
5 years · compounded
▲ 106%

Revenue fell 68% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 50%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.57 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3.43 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin7.8%
Net Profit Margin-0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rusi Pharma Pvt Ltd, buy the company report.

Board of directors of Rusi Pharma Pvt Ltd

Rusi Pharma has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
MonikaAdditional Director28 Jun 20215 Years 3 MonthsCurrent
Sudhir KumarAdditional Director25 Jan 20197 Years 9 MonthsCurrent

Auditor

Rusi Pharma Pvt Ltd is audited by RAHUL PRAMOD & ASSOCIATES for the financial year 2016.

Auditor firmFinancial yearFirm registration number
RAHUL PRAMOD & ASSOCIATESFY 2016512889C

Shareholding

The shareholding of Rusi Pharma Pvt Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rusi Pharma Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹6.01 Cr
Breakdown by lending institutions
Bank of Baroda₹5.70 Cr
Central Bank of India₹0.20 Cr
The Saraswat Co-Op Bank Ltd₹0.11 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jul 200490158437Bank of Baroda₹5.7 CrSatisfied
05 Feb 200090157401Central Bank of India₹20 LakhSatisfied
27 May 199790156593The Saraswat Co-Op Bank Ltd₹3 LakhSatisfied
19 Jun 199690156352The Saraswat Co-Op Bank Ltd₹4 LakhSatisfied
18 Jun 199390155846The Saraswat Co-Op Bank Ltd₹4 LakhSatisfied

To see the full charge records of Rusi Pharma Pvt Ltd, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rusi Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Rusi Pharma Pvt Ltd has 2 active EPFO establishments as of Apr 09, 2024.

Active EPFO establishments
2

GST

Rusi Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
05AAACR3203M2ZMUttarakhandActive23 Aug 2017

To see the full GST registrations and return filing status of Rusi Pharma Pvt Ltd, buy the company report.

Recent activity

Rusi Pharma Pvt Ltd has 14 board changes on record since 2011: 2 appointments and 12 cessations. The latest: Lekh Raj ceased to be Additional Director on 19 Dec 2023.

Ceased
Lekh Raj ceased to be Additional Director.
Ceased
Suresa Chanda ceased to be Additional Director.
Appointed
Monika was appointed as Additional Director.
Ceased
Monika ceased to be Additional Director.
AGM
Rusi Pharma Pvt Ltd last Annual general meeting of members was held on 03 Oct 2020 as per latest MCA records.
Filing
Rusi Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai I.
Appointed
Sudhir Kumar was appointed as Additional Director.
Ceased
Ramji Ramdas Jaiswal ceased to be Director.
Ceased
Ravi Ramji Jaiswal ceased to be Director.
Charges
A charge registered on 30 Jul 2004 via Charge ID 90158437 with Bank Of Baroda was fully satisfied on 11 Jun 2018.
Ceased
Saksham Gilhotra ceased to be Additional Director.
Ceased
Sudhir Kumar ceased to be Additional Director.

19 earlier events are in the company report.

Frequently asked questions

Rusi Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 1992 (34+ years old) and is registered under CIN U24230MH1992PTC069066.

Rusi Pharma has 2 current directors:

The latest financial statements of Rusi Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 03 October 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Rusi Pharma is 05AAACR3203M2ZM, registered in Uttarakhand. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Rusi Pharma is U24230MH1992PTC069066. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rusi Pharma has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.

Rusi Pharma was incorporated on 16 October 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.

Lekh Raj ceased to be Additional Director on 19 Dec 2023. Suresa Chanda ceased to be Additional Director on 19 Dec 2023. Monika was appointed as Additional Director on 28 Jun 2021. Rusi Pharma has 14 board changes on record in total.

Rusi Pharma can be reached through the website rusipharma.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Rusi Pharma is at Anchor Building A Flat No.4D104 New Mhada Complex Bhoomi Construction Malwani Mal, Ad West, Mumbai, Maharashtra, India – 400096.